Prognostic Factors of IIIAN2 Non-Small-Cell Lung Cancer after Complete Resection: A Systemic Review and Meta-analysis

Objective and Background. We designed this systemic review meta-analysis of all the reported scientific literature to conclude the prognostic factors of IIIAN2 non-small-cell lung cancer after complete surgical resection. Management of NSCLC IIIAN2 involved different strategies, such as complete res...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Computational and mathematical methods in medicine 2021-12, Vol.2021, p.1068090-8
Hauptverfasser: Wang, Youyu, Wan, Yanhui, Qian, Youhui
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 8
container_issue
container_start_page 1068090
container_title Computational and mathematical methods in medicine
container_volume 2021
creator Wang, Youyu
Wan, Yanhui
Qian, Youhui
description Objective and Background. We designed this systemic review meta-analysis of all the reported scientific literature to conclude the prognostic factors of IIIAN2 non-small-cell lung cancer after complete surgical resection. Management of NSCLC IIIAN2 involved different strategies, such as complete resection, chemotherapy, radiotherapy, chemoradiotherapy, and induction therapy. Each management strategy has its associated prognostic factor to monitor for better patient prognosis, recovery, survival rate, and minimize the chances of recurrence. Methods. An extensive data search was conducted from all leading databases including PubMed, Google Scholar, Embase, and Cochrane. Fifteen studies were selected according to the PRISMA model of data selected to conduct this systemic review meta-analysis. Results. Total 4444 patients were evaluated among fifteen selected studies. A number of lymph nodes involved (n=3965), level of lymph nodes (n=3422), and complete tumor resection (n=3255) were the most reported prognostic factors. Conclusion. This study exhibits the overall significance of all prognostic factors of NSCLC IIIAN2 pathology for better patient management. However, other management strategies also play a significant contribution to achieving a better survival rate and less recurrence possibility.
doi_str_mv 10.1155/2021/1068090
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8687771</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2613294145</sourcerecordid><originalsourceid>FETCH-LOGICAL-c420t-3875813457c7d1b8f5584b2f0b884e6c30665ded43832781a112f794900857aa3</originalsourceid><addsrcrecordid>eNp9kcFrFDEUhwdRbK3ePEuOgo7NyySTjIfCMlhdWKu0Ct5CNvNmG5lJ1iTTsv-9U3Zd9OLl5UE-vryXX1G8BPoOQIhzRhmcA60Vbeij4hQkV2UtQT0-9vTHSfEspZ-UCpACnhYnFW8qVXF5WkxfY9j4kLKz5NLYHGIioSfL5XJxxchV8OXNaIahbHEYyGryG9IabzES0-e5tmHcDpiRXGNCm13w78mC3OxSxnE2XuOdw3tifEc-Yzal8WbYJZeeF096MyR8cTjPiu-XH761n8rVl4_LdrEqLWc0l5WSQkHFhbSyg7XqhVB8zXq6VopjbSta16LDjs_LMKnAALBeNryhVAlpTHVWXOy922k9YmfR52gGvY1uNHGng3H63xvvbvUm3GlVKyklzILXB0EMvyZMWY8u2fkvjMcwJc1qqFjDgYsZfbtHbQwpReyPzwDVD0nph6T0IakZf_X3aEf4TzQz8GYP3DrfmXv3f91v8oKaUQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2613294145</pqid></control><display><type>article</type><title>Prognostic Factors of IIIAN2 Non-Small-Cell Lung Cancer after Complete Resection: A Systemic Review and Meta-analysis</title><source>MEDLINE</source><source>PubMed Central Open Access</source><source>Wiley-Blackwell Open Access Titles</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Wang, Youyu ; Wan, Yanhui ; Qian, Youhui</creator><contributor>Khalaf, Osamah Ibrahim</contributor><creatorcontrib>Wang, Youyu ; Wan, Yanhui ; Qian, Youhui ; Khalaf, Osamah Ibrahim</creatorcontrib><description>Objective and Background. We designed this systemic review meta-analysis of all the reported scientific literature to conclude the prognostic factors of IIIAN2 non-small-cell lung cancer after complete surgical resection. Management of NSCLC IIIAN2 involved different strategies, such as complete resection, chemotherapy, radiotherapy, chemoradiotherapy, and induction therapy. Each management strategy has its associated prognostic factor to monitor for better patient prognosis, recovery, survival rate, and minimize the chances of recurrence. Methods. An extensive data search was conducted from all leading databases including PubMed, Google Scholar, Embase, and Cochrane. Fifteen studies were selected according to the PRISMA model of data selected to conduct this systemic review meta-analysis. Results. Total 4444 patients were evaluated among fifteen selected studies. A number of lymph nodes involved (n=3965), level of lymph nodes (n=3422), and complete tumor resection (n=3255) were the most reported prognostic factors. Conclusion. This study exhibits the overall significance of all prognostic factors of NSCLC IIIAN2 pathology for better patient management. However, other management strategies also play a significant contribution to achieving a better survival rate and less recurrence possibility.</description><identifier>ISSN: 1748-670X</identifier><identifier>EISSN: 1748-6718</identifier><identifier>DOI: 10.1155/2021/1068090</identifier><identifier>PMID: 34938347</identifier><language>eng</language><publisher>United States: Hindawi</publisher><subject>Carcinoma, Non-Small-Cell Lung - pathology ; Carcinoma, Non-Small-Cell Lung - secondary ; Carcinoma, Non-Small-Cell Lung - surgery ; Computational Biology ; Humans ; Lung Neoplasms - pathology ; Lung Neoplasms - surgery ; Lymphatic Metastasis - pathology ; Neoplasm Staging ; Prognosis ; Review</subject><ispartof>Computational and mathematical methods in medicine, 2021-12, Vol.2021, p.1068090-8</ispartof><rights>Copyright © 2021 Youyu Wang et al.</rights><rights>Copyright © 2021 Youyu Wang et al. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c420t-3875813457c7d1b8f5584b2f0b884e6c30665ded43832781a112f794900857aa3</citedby><cites>FETCH-LOGICAL-c420t-3875813457c7d1b8f5584b2f0b884e6c30665ded43832781a112f794900857aa3</cites><orcidid>0000-0002-9303-9531</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687771/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687771/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34938347$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Khalaf, Osamah Ibrahim</contributor><creatorcontrib>Wang, Youyu</creatorcontrib><creatorcontrib>Wan, Yanhui</creatorcontrib><creatorcontrib>Qian, Youhui</creatorcontrib><title>Prognostic Factors of IIIAN2 Non-Small-Cell Lung Cancer after Complete Resection: A Systemic Review and Meta-analysis</title><title>Computational and mathematical methods in medicine</title><addtitle>Comput Math Methods Med</addtitle><description>Objective and Background. We designed this systemic review meta-analysis of all the reported scientific literature to conclude the prognostic factors of IIIAN2 non-small-cell lung cancer after complete surgical resection. Management of NSCLC IIIAN2 involved different strategies, such as complete resection, chemotherapy, radiotherapy, chemoradiotherapy, and induction therapy. Each management strategy has its associated prognostic factor to monitor for better patient prognosis, recovery, survival rate, and minimize the chances of recurrence. Methods. An extensive data search was conducted from all leading databases including PubMed, Google Scholar, Embase, and Cochrane. Fifteen studies were selected according to the PRISMA model of data selected to conduct this systemic review meta-analysis. Results. Total 4444 patients were evaluated among fifteen selected studies. A number of lymph nodes involved (n=3965), level of lymph nodes (n=3422), and complete tumor resection (n=3255) were the most reported prognostic factors. Conclusion. This study exhibits the overall significance of all prognostic factors of NSCLC IIIAN2 pathology for better patient management. However, other management strategies also play a significant contribution to achieving a better survival rate and less recurrence possibility.</description><subject>Carcinoma, Non-Small-Cell Lung - pathology</subject><subject>Carcinoma, Non-Small-Cell Lung - secondary</subject><subject>Carcinoma, Non-Small-Cell Lung - surgery</subject><subject>Computational Biology</subject><subject>Humans</subject><subject>Lung Neoplasms - pathology</subject><subject>Lung Neoplasms - surgery</subject><subject>Lymphatic Metastasis - pathology</subject><subject>Neoplasm Staging</subject><subject>Prognosis</subject><subject>Review</subject><issn>1748-670X</issn><issn>1748-6718</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>RHX</sourceid><sourceid>EIF</sourceid><recordid>eNp9kcFrFDEUhwdRbK3ePEuOgo7NyySTjIfCMlhdWKu0Ct5CNvNmG5lJ1iTTsv-9U3Zd9OLl5UE-vryXX1G8BPoOQIhzRhmcA60Vbeij4hQkV2UtQT0-9vTHSfEspZ-UCpACnhYnFW8qVXF5WkxfY9j4kLKz5NLYHGIioSfL5XJxxchV8OXNaIahbHEYyGryG9IabzES0-e5tmHcDpiRXGNCm13w78mC3OxSxnE2XuOdw3tifEc-Yzal8WbYJZeeF096MyR8cTjPiu-XH761n8rVl4_LdrEqLWc0l5WSQkHFhbSyg7XqhVB8zXq6VopjbSta16LDjs_LMKnAALBeNryhVAlpTHVWXOy922k9YmfR52gGvY1uNHGng3H63xvvbvUm3GlVKyklzILXB0EMvyZMWY8u2fkvjMcwJc1qqFjDgYsZfbtHbQwpReyPzwDVD0nph6T0IakZf_X3aEf4TzQz8GYP3DrfmXv3f91v8oKaUQ</recordid><startdate>20211213</startdate><enddate>20211213</enddate><creator>Wang, Youyu</creator><creator>Wan, Yanhui</creator><creator>Qian, Youhui</creator><general>Hindawi</general><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-9303-9531</orcidid></search><sort><creationdate>20211213</creationdate><title>Prognostic Factors of IIIAN2 Non-Small-Cell Lung Cancer after Complete Resection: A Systemic Review and Meta-analysis</title><author>Wang, Youyu ; Wan, Yanhui ; Qian, Youhui</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c420t-3875813457c7d1b8f5584b2f0b884e6c30665ded43832781a112f794900857aa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Carcinoma, Non-Small-Cell Lung - pathology</topic><topic>Carcinoma, Non-Small-Cell Lung - secondary</topic><topic>Carcinoma, Non-Small-Cell Lung - surgery</topic><topic>Computational Biology</topic><topic>Humans</topic><topic>Lung Neoplasms - pathology</topic><topic>Lung Neoplasms - surgery</topic><topic>Lymphatic Metastasis - pathology</topic><topic>Neoplasm Staging</topic><topic>Prognosis</topic><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Youyu</creatorcontrib><creatorcontrib>Wan, Yanhui</creatorcontrib><creatorcontrib>Qian, Youhui</creatorcontrib><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Computational and mathematical methods in medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Youyu</au><au>Wan, Yanhui</au><au>Qian, Youhui</au><au>Khalaf, Osamah Ibrahim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic Factors of IIIAN2 Non-Small-Cell Lung Cancer after Complete Resection: A Systemic Review and Meta-analysis</atitle><jtitle>Computational and mathematical methods in medicine</jtitle><addtitle>Comput Math Methods Med</addtitle><date>2021-12-13</date><risdate>2021</risdate><volume>2021</volume><spage>1068090</spage><epage>8</epage><pages>1068090-8</pages><issn>1748-670X</issn><eissn>1748-6718</eissn><abstract>Objective and Background. We designed this systemic review meta-analysis of all the reported scientific literature to conclude the prognostic factors of IIIAN2 non-small-cell lung cancer after complete surgical resection. Management of NSCLC IIIAN2 involved different strategies, such as complete resection, chemotherapy, radiotherapy, chemoradiotherapy, and induction therapy. Each management strategy has its associated prognostic factor to monitor for better patient prognosis, recovery, survival rate, and minimize the chances of recurrence. Methods. An extensive data search was conducted from all leading databases including PubMed, Google Scholar, Embase, and Cochrane. Fifteen studies were selected according to the PRISMA model of data selected to conduct this systemic review meta-analysis. Results. Total 4444 patients were evaluated among fifteen selected studies. A number of lymph nodes involved (n=3965), level of lymph nodes (n=3422), and complete tumor resection (n=3255) were the most reported prognostic factors. Conclusion. This study exhibits the overall significance of all prognostic factors of NSCLC IIIAN2 pathology for better patient management. However, other management strategies also play a significant contribution to achieving a better survival rate and less recurrence possibility.</abstract><cop>United States</cop><pub>Hindawi</pub><pmid>34938347</pmid><doi>10.1155/2021/1068090</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-9303-9531</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1748-670X
ispartof Computational and mathematical methods in medicine, 2021-12, Vol.2021, p.1068090-8
issn 1748-670X
1748-6718
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8687771
source MEDLINE; PubMed Central Open Access; Wiley-Blackwell Open Access Titles; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
subjects Carcinoma, Non-Small-Cell Lung - pathology
Carcinoma, Non-Small-Cell Lung - secondary
Carcinoma, Non-Small-Cell Lung - surgery
Computational Biology
Humans
Lung Neoplasms - pathology
Lung Neoplasms - surgery
Lymphatic Metastasis - pathology
Neoplasm Staging
Prognosis
Review
title Prognostic Factors of IIIAN2 Non-Small-Cell Lung Cancer after Complete Resection: A Systemic Review and Meta-analysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T07%3A46%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20Factors%20of%20IIIAN2%20Non-Small-Cell%20Lung%20Cancer%20after%20Complete%20Resection:%20A%20Systemic%20Review%20and%20Meta-analysis&rft.jtitle=Computational%20and%20mathematical%20methods%20in%20medicine&rft.au=Wang,%20Youyu&rft.date=2021-12-13&rft.volume=2021&rft.spage=1068090&rft.epage=8&rft.pages=1068090-8&rft.issn=1748-670X&rft.eissn=1748-6718&rft_id=info:doi/10.1155/2021/1068090&rft_dat=%3Cproquest_pubme%3E2613294145%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2613294145&rft_id=info:pmid/34938347&rfr_iscdi=true